Future leadership series sessions will be updated shortly
Dr Maria Rivas, Chief Medical Officer, Merck KGaA.
The Power of reinvention: taking on new career risks, roles, or directions
Thursday June 4 2020
Maria Rivas, MD, is Chief Medical Officer, heading both Global Medical Affairs and Global Evidence Value Development at the biopharmaceutical business of Merck KGaA, Darmstadt, Germany. Dr. Rivas and her team are responsible for bridging between Merck KGaA’s R&D innovation and the commercialization of promising products to positively impact the lives of patients. In her role as Chief Medical Officer at Merck KGaA, Darmstadt, Germany, Dr. Rivas reports to the Head of Global R&D and serves as a member of the R&D Executive Leadership Team.
Dr Orly Avitzur, President Elect of the American Academy of Neurology.
Multiple sclerosis in the mist of a pandemic: what has changed?
Wednesday 18 March 2020
Following our conversation, Dr Orly Avitzur (MD, MBA, FAAN) President-Elect of the AAN has written on the disruptions to clinical practice and research as a result of COVID-19, and experiences of clinicians and scientists working in our field. Find the article in Neurology Today.
More information on Dr Avitzur can be found here